Skip to main content

Table 4 Multivariate analysis of EP300 SNP rs20551 on survival in 226 DLBCL patients

From: EP300 single nucleotide polymorphism rs20551 correlates with prolonged overall survival in diffuse large B cell lymphoma patients treated with R-CHOP

Variable

Hazard ratio

95% CI

p

GA/AA

2.956

1.315–6.645

0.009

B symptom

0.502

0.271–0.928

0.028

β2-MG

2.239

1.201–4.175

0.011

IPI

2.435

1.362–4.354

0.003

Clinical response

0.06

0.030–0.120

<0.001